Looking forward: key initiatives to improve the care of rare diseases and streamline the delivery of medicines and vaccines in Europe
Am J Physiol Lung Cell Mol Physiol
.
2021 Sep 1;321(3):L616-L618.
doi: 10.1152/ajplung.00317.2021.
Epub 2021 Jul 28.
Authors
Marc Humbert
1
2
3
4
5
,
Anita K Simonds
6
7
8
Affiliations
1
Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, France.
2
Assistance Publique Hôpitaux de Paris, Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
3
INSERM UMR S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, France.
4
President, European Respiratory Society 2021-22, Lausanne, Switzerland.
5
European Reference Network on Rare Respiratory Diseases (ERN-LUNG), Frankfurt am Main, Germany.
6
Respiratory & Sleep Medicine, Royal Brompton & Harefield Hospital, London, United Kingdom.
7
Past President, European Respiratory Society (President 2020-21), Lausanne, Switzerland.
8
Emergency Covid Task Force, European Medicines Agency, Amsterdam, The Netherlands.
PMID:
34318703
DOI:
10.1152/ajplung.00317.2021
No abstract available
Keywords:
ERS; European Respiratory Society; WLD2021; World Lung Day; pulmonary medicine.
Publication types
Editorial
Comment
MeSH terms
Europe
Humans
Pulmonary Medicine*
Rare Diseases / drug therapy
Vaccines*
Substances
Vaccines